Northwest & Ethical Investments’s 10x Genomics TXG Stock Holding History

Northwest & Ethical Investments’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-44,555	Closed	-$2.49M	–	508
2023 Q4	$2.49M	Hold	44,555	–	–	0.08%	227
2023 Q3	$1.84M	Sell	44,555 -1,163	-3%	-$60.5K	0.06%	236
2023 Q2	$2.55M	Buy	45,718 +1,862	+4%	+$101K	0.08%	230
2023 Q1	$2.45M	Hold	43,856	–	–	0.08%	231
2022 Q4	$1.6M	Buy	43,856 +5,455	+14%	+$178K	0.06%	265
2022 Q3	$1.09M	Hold	38,401	–	–	0.04%	282
2022 Q2	$1.74M	Buy	38,401 +9,937	+35%	+$516K	0.07%	253
2022 Q1	$2.17M	Buy	28,464 +19,539	+219%	+$1.71M	0.07%	244
2021 Q4	$1.33M	Buy	+8,925	New	+$1.37M	0.04%	275

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Northwest & Ethical Investments's TXG Position: Q1 2024 in Review

Northwest & Ethical Investments sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 44,555 shares — an estimated $2.49M sold.

Northwest & Ethical Investments first reported a position in TXG in Q4 2021 and held it in 9 quarters. The position peaked at $2.55M in Q2 2023. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

Northwest & Ethical Investments reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
Northwest & Ethical Investments sold 44,555 10x Genomics shares in Q1 2024, an estimated $2.49M.
Northwest & Ethical Investments first reported a position in 10x Genomics in Q4 2021 and held it in 9 quarters.
Northwest & Ethical Investments's 10x Genomics position peaked at $2.55M in Q2 2023.
290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Northwest & Ethical Investments's 13F filing for Q1 2024, filed 9 Jul 2025.